BlossomHill Therapeutics (BLSM) Financials: Revenue & Earnings

BLSM price $15.76 +0.01 +0.03%

Ticker
BLSM
Price
$15.76
Change
+0.01 +0.03%
Market cap ?
$458.32M
Sector
Healthcare
Industry
Biotechnology

Fair value

BLSM fair value Not meaningful. Price $15.76.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare BLSM

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-12-18—-0.93——
2026-09-18-8.75-0.93——

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-10GORDON CARL LBuy625.00K$16.0010.00M
2026-08-10GORDON CARL LBuy1.05M——
2026-08-10GORDON CARL LBuy1.04M——
2026-08-10GORDON CARL LSell1.05M——
2026-08-10GORDON CARL LSell1.04M——
2026-08-10ORBIMED ADVISORS LLCBuy625.00K$16.0010.00M
2026-08-10ORBIMED ADVISORS LLCBuy1.05M——
2026-08-10ORBIMED ADVISORS LLCBuy1.04M——
2026-08-10ORBIMED ADVISORS LLCSell1.05M——
2026-08-10ORBIMED ADVISORS LLCSell1.04M——
2026-08-10Schmid John P.Buy6.00K$16.0096.00K
2026-08-10Chen BihuaBuy312.50K$16.005.00M
2026-08-10Chen BihuaBuy1.70M——
2026-08-10Chen BihuaBuy1.60M——
2026-08-10Chen BihuaSell1.60M——
2026-08-10Chen BihuaSell1.70M——
2026-08-10Agrawal SundeepBuy578.52K——
2026-08-10Agrawal SundeepSell578.52K——
2026-08-10Keyes Jason ABuy700$16.0011.20K
2026-08-10Liptak Vincent PaulBuy2.20K$16.0035.20K
2026-08-10Liptak Vincent PaulBuy22.69K——
2026-08-10Liptak Vincent PaulSell22.69K——
2026-08-10Li YishanBuy113.44K——
2026-08-10Li YishanBuy1.60M——
2026-08-10Li YishanBuy124.78K——
2026-08-10Li YishanSell1.60M——
2026-08-10Li YishanSell113.44K——
2026-08-10Li YishanSell124.78K——
2026-08-10Cui Jingrong JeanBuy113.44K——
2026-08-10Cui Jingrong JeanBuy1.60M——
2026-08-10Cui Jingrong JeanBuy124.78K——
2026-08-10Cui Jingrong JeanSell1.60M——
2026-08-10Cui Jingrong JeanSell113.44K——
2026-08-10Cui Jingrong JeanSell124.78K——
2026-08-07Liptak Vincent PaulBuy2.50K$15.8039.50K
2026-08-06GORDON CARL LBuy23.90K$16.00382.46K
2026-08-06Chen BihuaBuy23.90K$16.00382.46K
2026-08-06Agrawal SundeepBuy23.90K$16.00382.46K
2026-08-06Keyes Jason ABuy56.75K$16.00907.94K
2026-08-06Liptak Vincent PaulBuy46.56K$16.00744.98K
2026-08-06Oxnard Geoffrey RaymondBuy61.78K$16.00988.53K
2026-08-06Li YishanBuy112.70K$16.001.80M
2026-08-06Cui Jingrong JeanBuy676.21K$16.0010.82M
2026-08-06ORBIMED ADVISORS LLCOther1.04M——
2026-08-06ORBIMED ADVISORS LLCOther1.05M——
2026-08-06Schmid John P.Other67.62K$13.59918.96K
2026-08-06GUJRATHI SHEILAOther0——
2026-08-06Agrawal SundeepOther10.67K$6.2867.01K
2026-08-06Agrawal SundeepOther578.52K——
2026-08-06GORDON CARL LOther1.04M——
2026-08-06GORDON CARL LOther1.05M——
2026-08-06Chen BihuaOther1.70M——
2026-08-06Chen BihuaOther1.60M——
2026-08-06Liptak Vincent PaulOther0——
2026-08-06Liptak Vincent PaulOther22.69K——
2026-08-06Oxnard Geoffrey RaymondOther0——
2026-08-06Oxnard Geoffrey RaymondOther152.37K$5.63857.86K
2026-08-06Oxnard Geoffrey RaymondOther34.03K$6.28213.71K
2026-08-06Keyes Jason AOther175.42K$6.281.10M
2026-08-06Li YishanOther0——
2026-08-06Li YishanOther1.60M——
2026-08-06Li YishanOther124.78K——
2026-08-06Li YishanOther113.44K——
2026-08-06Cui Jingrong JeanOther0——
2026-08-06Cui Jingrong JeanOther1.60M——
2026-08-06Cui Jingrong JeanOther124.78K——
2026-08-06Cui Jingrong JeanOther113.44K——
2010-08-12Anderson John DavidSell0——

Institutional holders

HolderSharesChangeChange %Value
No data yet.

Earnings and financials

BlossomHill Therapeutics, Inc. (BLSM) trades at $15.76, with a market cap of $458.32M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

BlossomHill Therapeutics (BLSM) Financials: Revenue & Earnings

BLSM$15.76+0.01 +0.03%

$458.32M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History